Superbugs, with their inherent resistance to multiple antibiotics, have become a pressing global concern, demanding innovative research and effective countermeasures. Ace Therapeutics, a leading pioneer in biotechnology and research services, stands at the forefront of combating superbugs by offering a comprehensive suite of services tailored to meet the unique demands of superbug research.

Common Superbugs

Superbugs encompass a wide array of antibiotic-resistant bacteria, such as

  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • Vancomycin-resistant Enterococcus (VRE)
  • Carbapenem-resistant Enterobacteriaceae (CRE)
  • Extended-spectrum Beta-lactamase (ESBL) producing bacteria

These organisms have acquired genetic mutations or acquired resistance genes, rendering them impervious to conventional antibiotics, thus posing significant challenges in clinical settings.

Introduction to Superbug Research

Superbug research involves a multidisciplinary approach, encompassing microbiology, genetics, biochemistry, pharmacology, and more. It aims to unravel the mechanisms of antibiotic resistance, study the epidemiology of superbugs, and develop effective strategies to combat these microbial adversaries. We recognize the urgency of this research and offer a wide range of cutting-edge services to empower scientists and healthcare professionals in their quest to understand and mitigate the impact of superbugs.

Our Services

In addition to the few resistant bacteria already described above, there are still many bacteria that have gradually become resistant to certain antibiotics. Therefore, basic research on these known or unknown resistant bacteria is particularly important. We offer superbug identification and antibiotic resistance assays to better understand its resistance and target it more effectively. We hope that these good tests, which continue to improve, will help reverse the rise of superbugs.

Superbugs pose a significant threat to public health, as infections caused by superbugs are more difficult to treat and can lead to higher morbidity and mortality rates. To combat this threat, researchers and pharmaceutical companies have been developing new drugs to fight these superbugs. We focus on superbug research to discuss the latest advances in anti-superbug drug and therapy development and offer a variety of development services, including antimicrobial peptides, antibiotic adjuvants, antibodies, phages, and vaccines.

In an era where the threat of superbug infections looms large, the need for specific therapies to combat these resilient pathogens is more crucial than ever. We are at the forefront of developing groundbreaking solutions to tackle various superbug infections. We provide comprehensive and specific development services for specific therapies for different superbug infections, such as A. baumannii, P. aeruginosa and Enterobacterales.

Services Features

  • Comprehensive Data Analysis
  • Tailored Experimental Design
  • Collaborative Research Opportunities

Contact Us Now

To embark on an exciting journey in superbug research, contact Ace Therapeutics today. Our team of dedicated experts is ready to assist you in every aspect of your research, providing unparalleled support, cutting-edge technologies, and the burstiness needed to make significant strides in this critical field.

Ace Therapeutics offers a comprehensive range of services designed to empower researchers in their quest to combat antibiotic-resistant bacteria. By leveraging state-of-the-art technologies, fostering collaboration, and providing tailored solutions, we stand as an invaluable partner in the fight against superbugs. Together, we can unravel the mysteries of antibiotic resistance and develop novel therapies.

All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Get in touch with our team immediately.